Secondcell Bio

Secondcell Bio is a privately held biotechnology company based in the United States. With a team of three employees, the company has generated $2.5 million in revenue. Secondcell Bio's core offering is Chromovert®, a revolutionary cellular engineering biotechnology originating from a Nobel Prize-winning laboratory at The Rockefeller University. This technology enables the rapid purification of rare, optimally engineered cells, a crucial step in drug discovery, personalized medicine, and other biotechnological applications. Chromovert® has already demonstrated its potential in various fields. It played a role in the discovery of a novel nonaddictive painkiller, which led to an initial public offering filing with the U.S. Securities and Exchange Commission. The technology was also utilized in research collaborations with major food and beverage companies like The Coca-Cola Company, Kraft Foods, and Nestle, resulting in the development of new natural sweeteners and salty-taste enhancers. For more information about Secondcell Bio and its Chromovert® technology, please visit secondcellbio.com.